Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,008 | -96,953 | -69,635 | -37,381 | -115,252 |
| Depreciation Amortization | 2,700 | 2,047 | 1,350 | 525 | 1,528 |
| Accounts receivable | -1,474 | -1,440 | -1,857 | N/A | N/A |
| Accounts payable and accrued liabilities | -250 | 2,129 | 5,486 | 2,890 | 979 |
| Other Working Capital | -2,289 | -383 | 1,832 | -1,404 | 3,788 |
| Other Operating Activity | 22,106 | 14,548 | 6,584 | 1,099 | 11,454 |
| Operating Cash Flow | $-102,215 | $-80,052 | $-56,240 | $-34,271 | $-97,503 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,715 | -6,615 | -6,061 | -1,814 | -3,438 |
| Investing Cash Flow | $-6,715 | $-6,615 | $-6,061 | $-1,814 | $-3,438 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 510 | 365 | 0 | N/A | N/A |
| Other Financing Activity | 211,061 | 211,061 | 211,061 | 36,085 | 100,941 |
| Financing Cash Flow | $211,571 | $211,426 | $211,061 | $36,085 | $100,941 |
| Exchange Rate Effect | -20 | 1 | -4 | N/A | 0 |
| End Cash Position | 102,621 | 124,760 | 148,756 | N/A | 0 |
| Net Cash Flow | $102,621 | $124,760 | $148,756 | $N/A | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,215 | -80,052 | -56,240 | -34,271 | -97,503 |
| Capital Expenditure | -6,888 | -6,714 | -6,061 | -1,814 | -3,438 |
| Free Cash Flow | -109,103 | -86,766 | -62,301 | -36,085 | -100,941 |